SIGYN THERAPEUTICS, INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
SIGYN THERAPEUTICS, INC. (SIGY) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $2.10 thousand as of 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2023-03-31
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $2.10K.
- 2022-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $2.10K.
- 2022-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $2.10K.
- 2022-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $2.10K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One | Finite-Lived Intangible Asset, Expected Amortization, Year One as first filed |
|---|---|---|
| 2022-12-31 | $2.10K 10-K · filed 2023-03-31 | |
| 2022-09-30 | $2.10K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $2.10K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $2.10K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $3.60K 10-K · filed 2022-03-21 | |
| 2021-09-30 | $3.60K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $3.60K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $3.60K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $16.21K 10-K · filed 2021-04-06 | |
| 2020-09-30 | $3.60K 8-K/A · filed 2020-12-30 | $9.46K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $18.91K 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $28.36K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $37.82K 10-K · filed 2020-03-30 | |
| 2019-03-31 | $46.61K 10-Q · filed 2019-04-19 | |
| 2018-12-31 | $62.91K 10-K · filed 2019-04-01 | |
| 2018-09-30 | $117.80K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $117.80K 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $175.33K 10-Q · filed 2018-05-15 |